Teva shares surge 5% on news of patent settlement with Neos over ADHD drug [MarketWatch]
NEOS THERAPEUTICS (NEOS)
Last neos therapeutics earnings: 8/8 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
neostx.com
Company Research
Source: MarketWatch
Teva shares surge 5% on news of patent settlement with Neos over ADHD drug Shares of generic-drug maker Teva Pharmaceuticals Industries Ltd. rose about 5% Wednesday on news of a settlement and licensing agreement with Neos Therapeutics Inc. to resolve a patent dispute about a treatment for attention deficit disorders, or ADHD. Neos NEOS, -2.53% said the confidential agreement grants Teva TEVA, +7.30% the right to make and market its generic version of Cotempla XR-ODT under a TEVA Abbreviated New Drug Application starting July 1, 2026, or earlier under certain circumstances. Cotempla is an extended-release oral tablet used to treat the disorder, which affects about 4.4% of U.S. adults, according to the Attention Deficit Disorder Association. “We are pleased to have reached this settlement and will continue to defend our innovative medicines against any challenge,” said Jerry McLaughlin, Chief Executive Officer of Neos Therapeutics, in a statement. Neos specializes in developing m
Show less
Read more
Impact Snapshot
Event Time:
NEOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEOS alerts
High impacting NEOS THERAPEUTICS news events
Weekly update
A roundup of the hottest topics